GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30

Product NDC: 62032-131
11-digit product format: 620320131
Labeler code: 62032
Product ID: 62032-131_13520a24-3b31-4653-9cd1-5cb1ef1c742d
Type: HUMAN OTC DRUG
Nonproprietary name: HOMOSALATE, OCTINOXATE, OCTOCRYLENE, and ZINC OXIDE
Dosage form: CREAM
Route: TOPICAL
Labeler: Obagi Medical Products, Inc., a division of Valeant Pharmaceuticals North America LLC.
Application: part352
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2013-10-15
Marketing end: 0000-00-00
Substance: HOMOSALATE; OCTINOXATE; OCTOCRYLENE; ZINC OXIDE
Active strength: 120 mg/g; mg/g; mg/g; mg/g
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	62032-131		I	Inactivated by FDA		2026-10-05
excluded package	package	62032-131	62032-131-70	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	62032-131-70	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	62032-131-70	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	62032-131-70	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	62032-131-70	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62032-131-70	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62032-131-70	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62032-131-70	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62032-131-70	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62032-131-70	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	62032-131-70	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	62032-131-70	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	62032-131-70	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	62032-131-70	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	62032-131-70	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	62032-131-70	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	62032-131-70	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	62032-131-70	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	62032-131-70	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	62032-131-70	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	62032-131-70	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	62032-131-70	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	62032-131-70	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
62032-131-70	2020-01-31	C162847	48780-1	9d75b9d0-1a89-f424-e053-dadaa90a57ce	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN CREAM

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
62032-131-70	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30SUNSCREEN	50 g in 1 TUBE	CREAM	50		2
62032-131-70	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30SUNSCREEN	1 in 1 CARTON	CREAM	1		2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
HOMOSALATE	ACTIVE INGREDIENT	V06SV4M95S	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
OCTINOXATE	ACTIVE INGREDIENT	4Y5P7MUD51	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
OCTOCRYLENE	ACTIVE INGREDIENT	5A68WGF6WM	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
ZINC OXIDE	ACTIVE INGREDIENT	SOI2LOH54Z	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
HOMOSALATE	ACTIVE MOIETY	V06SV4M95S	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
OCTINOXATE	ACTIVE MOIETY	4Y5P7MUD51	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
OCTOCRYLENE	ACTIVE MOIETY	5A68WGF6WM	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
ZINC OXIDE	ACTIVE MOIETY	SOI2LOH54Z	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
ALUMINUM STARCH OCTENYLSUCCINATE	INACTIVE INGREDIENT	I9PJ0O6294	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
BEHENTRIMONIUM METHOSULFATE	INACTIVE INGREDIENT	5SHP745C61	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
BORON NITRIDE	INACTIVE INGREDIENT	2U4T60A6YD	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)	INACTIVE INGREDIENT	Z135WT9208	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
CERAMIDE 1	INACTIVE INGREDIENT	5THT33P7X7	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
CERAMIDE 3	INACTIVE INGREDIENT	4370DF050B	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
CERAMIDE 6 II	INACTIVE INGREDIENT	F1X8L2B00J	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
CETOSTEARYL ALCOHOL	INACTIVE INGREDIENT	2DMT128M1S	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
CHOLESTEROL	INACTIVE INGREDIENT	97C5T2UQ7J	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
DIETHYLENE GLYCOL MONOETHYL ETHER	INACTIVE INGREDIENT	A1A1I8X02B	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
DIMETHICONE 100	INACTIVE INGREDIENT	RO266O364U	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
HYALURONATE SODIUM	INACTIVE INGREDIENT	YSE9PPT4TH	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
KINETIN	INACTIVE INGREDIENT	P39Y9652YJ	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
NIACINAMIDE	INACTIVE INGREDIENT	25X51I8RD4	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
PEG-12 GLYCERYL DIMYRISTATE	INACTIVE INGREDIENT	VS4W16AQ3X	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
PHYTOSPHINGOSINE	INACTIVE INGREDIENT	GIN46U9Q2Q	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
SODIUM LAUROYL LACTYLATE	INACTIVE INGREDIENT	7243K85WFO	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
ZEATIN	INACTIVE INGREDIENT	7I6OOJ9GR6	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
62032-131	GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN (HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2	Legacy NDC, 2 package rows	20150619_5222ba81-bb97-4f0a-a465-f61c0b1d28a4.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
V06SV4M95S	HOMOSALATE	118-56-9	HOMOSALATE
4Y5P7MUD51	OCTINOXATE	83834-59-7	OCTINOXATE
5A68WGF6WM	OCTOCRYLENE	6197-30-4	OCTOCRYLENE
SOI2LOH54Z	ZINC OXIDE	1314-13-2	ZINC OXIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
62032-131-70	62032013170	50 g in 1 TUBE	50 g	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
GENTLE REJUVENATION ULTRA LIGHT REPAIR SPF 30 SUNSCREEN CREAM	Obagi Medical Products, Inc., a division of Valeant Pharmaceuticals North America LLC. \| LABORATOIRE DR RENAUD INC.	2013-10-15	HUMAN OTC DRUG LABEL	2